Association for Behavior Analysis International

The Association for Behavior Analysis International® (ABAI) is a nonprofit membership organization with the mission to contribute to the well-being of society by developing, enhancing, and supporting the growth and vitality of the science of behavior analysis through research, education, and practice.


38th Annual Convention; Seattle, WA; 2012

Event Details

Previous Page


Panel #197
Professional Development Series: An Introduction to Behavioral Pharmacology and Toxicology
Sunday, May 27, 2012
2:00 PM–3:20 PM
615 (Convention Center)
Area: BPH/EAB; Domain: Basic Research
Chair: Andrew Shen (Auburn University)
M. CHRISTOPHER NEWLAND (Auburn University)
EDWARD LEVIN (Duke University)
KAREN G. ANDERSON (West Virginia University)
W. KENT ANGER (Oregon Health & Science University)

Experimental research in pharmacology and toxicology has led to the discovery and development of drugs used to treat physical and mental illnesses. Additionally, toxicological research has led to the identification of environmental toxins, their biological and behavior consequences, and prevention programs aimed at reducing human and non-human exposure. Investigating pharmacology and toxicology without the associated behavioral components would be impractical. Therefore, the experimental analysis of behavior in the context of drugs and toxicants is of the utmost importance. This panel discussion seeks to explore some of the opportunities available in the fields of behavioral pharmacology and toxicology, as well as outlining some of the basic research within these fields and how these fields can inform biological and behavioral science. Topics of interest include answering behavioral questions with toxicology, developing meaningful and sensitive tests for behavioral toxicology in Zebrafish, and delay discounting in relation to drugs.

Keyword(s): behavioral pharmacology, behavioral toxicology, delay discounting, zebra fish



Back to Top
Modifed by Eddie Soh